Akamai Technologies enters the post-earnings week in a rare position: a stock up 27% in five days, a short base that just started to crack, and Wall Street scrambling to catch up. The tension is real — short interest at 11.3% of the float remains elevated, but the direction shifted sharply after last week's Q1 print.
The earnings catalyst was decisive. Akamai reported on May 7 and the stock jumped 21% the following session — one of the largest single-day moves in the company's recent history. That print appears to have been the trigger for a significant short-covering wave. Short interest dropped roughly 6.6% over the past week, falling from around 12.2% of the float at the start of the week to 11.3% by Tuesday. In absolute terms, approximately 1.3 million shorted shares were returned, a meaningful but not complete unwind. With 11.3% of the free float still short, there is no shortage of remaining fuel. Borrow conditions remain relaxed — cost to borrow is just 0.51% annualised, barely budging over the past month. Availability is wide, with the lending pool comfortably supplied. There is no squeeze dynamic here; shorts are covering on conviction, not necessity.
Options positioning adds a nuanced counter-signal. The put/call ratio climbed to 0.60 on Tuesday, nearly two standard deviations above its 20-day mean of 0.52. That is the most defensive options read in several weeks, and close to the top of the past year's range. After a 27% rally, some traders are clearly reaching for downside protection — whether to hedge long exposure or position for a fade. The z-score of 1.99 does not signal panic, but it does suggest the options market is more cautious than it was before the print.
The Street's reaction was broad and uniformly positive. At least eight firms raised their price targets in the 48 hours following results, with targets landing between $150 and $195. The standout move came this morning: Bank of America upgraded AKAM from Neutral to Buy and lifted its target from $130 to $175 — a decisive shift from a firm that had been on the sidelines. Susquehanna moved its target from $120 to $175. Keybanc went furthest, nudging to $195. With the stock near $149, the consensus target of $153.63 implies only modest upside from current levels at the midpoint — though the bulls (12 buys vs. 7 holds) clearly see more room to run. The bull case centres on the $1.8 billion AI compute deal and Akamai's network architecture advantage in AI inference delivery. Bears flag capital intensity risks: colocation costs are compressing near-term margins, and the fear is that the stock may already reflect the benefit of the large deal pipeline. The ORTEX short score of 55.3 — mid-range and drifting slightly lower this week — is consistent with a market leaning cautiously constructive rather than aggressively bearish.
Valuation re-rated sharply through the earnings move. The price-to-earnings multiple expanded by roughly 8 points over the past 30 days, reaching 21.6x. Price-to-book climbed 1.5 turns over the same period to 3.9x. Both moves reflect the stock's re-rating from a value-discounted CDN business to an AI-infrastructure growth name. The EV/EBITDA of 13.7x has been relatively stable, suggesting the market is paying for earnings growth rather than applying an entirely new framework. Factor scores are mixed: the analyst recommendation divergence rank is in the 94th percentile, meaning the current Street setup is more bullish than almost all other names in the universe — a useful but potentially contrarian signal at these levels.
On the ownership side, First Trust added nearly one million shares in the most recent reporting period, the largest single institutional change in the top-holder list. Dimensional Fund Advisors added 784,000 shares. Insider activity, meanwhile, was one-directional — a cluster of executive sells in mid-March at prices around $105-$108, well below current levels. Those trades carry low significance scores and are now stale relative to the earnings event, so they offer little forward read.
Close peers were notably weaker on the week. FSLY fell 41% over the same five-day window — a stark divergence from Akamai's 27% gain — likely driven by Fastly's own separate results rather than sector pressure. DOCN and OKTA both gained around 2%, modest moves that underscore how much of Akamai's move was company-specific rather than sector-driven.
What to watch next: the remaining short base at 11.3% of float is the live variable. Whether that position continues to unwind gradually — or firms back up as the post-earnings excitement fades — will likely be the cleanest read on whether the Street's newly upgraded thesis is gaining or losing traction.
See the live data behind this article on ORTEX.
Open AKAM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
